Yaohui G Xu
Overview
Explore the profile of Yaohui G Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Y, Lim Y, Bordeaux J, Aasi S, Alam M, Chen P, et al.
J Natl Compr Canc Netw
. 2024 Nov;
22(9).
PMID: 39536442
Peripheral and deep en face margin assessment (PDEMA), formerly termed by NCCN as complete circumferential peripheral and deep margin assessment (CCPDMA), has the advantages of histologic visualization of the entire...
2.
Sable K, Korger S, Xu Y, Bennett D, Hinshaw M, Rosin A
Cutis
. 2024 Jul;
113(5):211-213.
PMID: 39042123
With the increasing utilization of telemedicine since the COVID-19 pandemic, it is critical that clinicians have an appropriate understanding of the application of virtual care resources, including teledermatology. We present...
3.
Sable K, Weinhammer A, Rudningen K, Xu Y
JAAD Int
. 2023 Oct;
13:164-165.
PMID: 37823047
No abstract available.
4.
5.
Sable K, Rudningen K, Lasarev M, Xu Y
Arch Dermatol Res
. 2023 May;
315(9):2683-2687.
PMID: 37222796
In 2022, National Comprehensive Cancer Network updated the phrase of "complete circumferential peripheral and deep margin assessment (CCPDMA)" to "peripheral and deep en face margin assessment (PDEMA)," which was meant...
6.
Mafee M, Buhalog B, Liang M, Yu M, Aylward J, Xu Y
Arch Dermatol Res
. 2023 Mar;
315(7):2163-2165.
PMID: 36877309
A length-to-width ratio (LWR) of 3:1 for linear closures is often cited in the literature. However, there are limited studies evaluating this ratio in relation to various surgical sites. This...
7.
Weinhammer A, Bennett D, Eickhoff J, Xu Y
Dermatol Surg
. 2022 Jul;
48(9):1001-1003.
PMID: 35862695
No abstract available.
8.
Wiener A, Schumacher J, Racz J, Weber S, Xu Y, Neuman H
Ann Surg Oncol
. 2022 May;
29(9):5925-5932.
PMID: 35505144
Background: Cutaneous melanoma survivors are at increased risk of a second primary melanoma. Valid estimates facilitate counseling on recommended surveillance after a melanoma diagnosis. However, most estimates of 5- and...
9.
Prasad A, Shields B, Xu Y, Aylward J, Hinshaw M
J Cutan Pathol
. 2022 Apr;
49(7):675-677.
PMID: 35416321
No abstract available.
10.
Schmults C, Blitzblau R, Aasi S, Alam M, Andersen J, Baumann B, et al.
J Natl Compr Canc Netw
. 2021 Dec;
19(12):1382-1394.
PMID: 34902824
The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually...